Sign up to save your podcasts
Or
Share Holistic Health and Psychedelic Medicine with Maria Velkova
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Holistic Health and Psychedelic Medicine with Maria Velkova
I sit down with Maria Velkova, Managing Partner at Tabula Rasa Ventures, to explore the groundbreaking potential of psychedelic medicine and its role in transforming the future of healthcare. Maria shares her journey from Big Pharma to venture capital, driven by a deep passion for revolutionising health systems and addressing the root causes of mental health issues.
We delve into the current state of psychedelic research, focusing on substances like psilocybin and MDMA, and how they offer new hope for treating conditions such as PTSD, depression, and anxiety. Maria explains the science behind these therapies, how they work to rewire the brain, and why they are poised to reshape the way we think about and approach mental health.
But it’s not just about the science—Maria brings a deeply personal perspective to the conversation, sharing how her own experiences have shaped her mission to build a more holistic and effective healthcare system. She discusses the challenges and opportunities in integrating these novel therapies into mainstream medicine and offers her vision for a future where healthcare is not just reactive, but truly preventative and personalised.
What You’ll Discover:
Tune in to discover how psychedelic medicine could be the key to a more compassionate, effective, and sustainable future in healthcare.
---
About Maria:
Maria Velkova, Managing Partner at Tabula Rasa Ventures, specializes in investing at the intersection of legacy health systems and wellness care. With over a decade as a big pharma executive for Roche, AstraZeneca, Novartis, and others, Maria's expertise spans global drug development and health system strategy. Recognized among Business Insider's top 15 Global Psychedelics Executives, she has led high-profile events at Davos, alongside the World Economic Forum, and pioneered education on psychedelics at the 'Dialogues in Mental Health” conference in Dubai—the first in the Arab Region. Maria holds a degree in BSc Pharmacology from Leeds University and MPhil in Bioscience Enterprise from Cambridge University, where she was a visiting lecturer in 2016.
Learn more about Maria/Tabula Rasa Ventures:
https://www.linkedin.com/in/maria-velkova/
https://www.tabularasa.ventures/
Connect with humanplus:
LI: https://www.linkedin.com/company/humanplusfutures
IG: @humanplusfutures
Connect with Kat:
LI: www.linkedin.com/in/katharinakugler
E-mail: [email protected]
View all episodes
By Katharina KuglerI sit down with Maria Velkova, Managing Partner at Tabula Rasa Ventures, to explore the groundbreaking potential of psychedelic medicine and its role in transforming the future of healthcare. Maria shares her journey from Big Pharma to venture capital, driven by a deep passion for revolutionising health systems and addressing the root causes of mental health issues.
We delve into the current state of psychedelic research, focusing on substances like psilocybin and MDMA, and how they offer new hope for treating conditions such as PTSD, depression, and anxiety. Maria explains the science behind these therapies, how they work to rewire the brain, and why they are poised to reshape the way we think about and approach mental health.
But it’s not just about the science—Maria brings a deeply personal perspective to the conversation, sharing how her own experiences have shaped her mission to build a more holistic and effective healthcare system. She discusses the challenges and opportunities in integrating these novel therapies into mainstream medicine and offers her vision for a future where healthcare is not just reactive, but truly preventative and personalised.
What You’ll Discover:
Tune in to discover how psychedelic medicine could be the key to a more compassionate, effective, and sustainable future in healthcare.
---
About Maria:
Maria Velkova, Managing Partner at Tabula Rasa Ventures, specializes in investing at the intersection of legacy health systems and wellness care. With over a decade as a big pharma executive for Roche, AstraZeneca, Novartis, and others, Maria's expertise spans global drug development and health system strategy. Recognized among Business Insider's top 15 Global Psychedelics Executives, she has led high-profile events at Davos, alongside the World Economic Forum, and pioneered education on psychedelics at the 'Dialogues in Mental Health” conference in Dubai—the first in the Arab Region. Maria holds a degree in BSc Pharmacology from Leeds University and MPhil in Bioscience Enterprise from Cambridge University, where she was a visiting lecturer in 2016.
Learn more about Maria/Tabula Rasa Ventures:
https://www.linkedin.com/in/maria-velkova/
https://www.tabularasa.ventures/
Connect with humanplus:
LI: https://www.linkedin.com/company/humanplusfutures
IG: @humanplusfutures
Connect with Kat:
LI: www.linkedin.com/in/katharinakugler
E-mail: [email protected]